Murkowski Urges FDA Nom. To Advance The 'Acceleration Approval Pathway’ For Rare Disease Treatment скачать в хорошем качестве

Murkowski Urges FDA Nom. To Advance The 'Acceleration Approval Pathway’ For Rare Disease Treatment

During Thursday’s Senate Health, Education, Labor, and Pension Committee hearing, Sen. Lisa. Murkowski (R-AK) questioned Trump’s FDA Commissioner Nominee Martin Makary about ALS treatment and the FDA acceleration approval pathway for the treatments to rare diseases. Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more: https://account.forbes.com/membership... Stay Connected Forbes on Facebook: http://fb.com/forbes Forbes Video on Twitter:   / forbes   Forbes Video on Instagram:   / forbes   More From Forbes: http://forbes.com